End-of-day quote
Johannesburg S.E.
06:00:00 2024-04-28 pm EDT
|
5-day change
|
1st Jan Change
|
94.34
ZAR
|
+1.57%
|
|
+2.10%
|
-13.99%
|
Fiscal Period: December |
2019
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
11,764
|
12,314
|
9,243
|
11,574
|
9,955
|
-
|
-
|
Enterprise Value (EV)
1 |
11,764
|
12,314
|
14,588
|
11,574
|
11,564
|
9,796
|
7,580
|
P/E ratio
|
-
|
10.1
x
|
9.98
x
|
9.86
x
|
6.17
x
|
4.65
x
|
3.75
x
|
Yield
|
5.33%
|
-
|
8.84%
|
-
|
4.05%
|
7.17%
|
-
|
Capitalization / Revenue
|
0.47
x
|
0.47
x
|
0.26
x
|
0.31
x
|
0.26
x
|
0.24
x
|
0.22
x
|
EV / Revenue
|
0.47
x
|
0.47
x
|
0.41
x
|
0.31
x
|
0.3
x
|
0.24
x
|
0.17
x
|
EV / EBITDA
|
3.54
x
|
-
|
4.09
x
|
3.14
x
|
2.77
x
|
2.08
x
|
1.38
x
|
EV / FCF
|
-
|
-
|
-6.53
x
|
-
|
4.82
x
|
4.16
x
|
2.43
x
|
FCF Yield
|
-
|
-
|
-15.3%
|
-
|
20.8%
|
24.1%
|
41.1%
|
Price to Book
|
-
|
-
|
-
|
-
|
0.73
x
|
0.67
x
|
-
|
Nbr of stocks (in thousands)
|
109,944
|
109,944
|
105,518
|
105,518
|
105,518
|
-
|
-
|
Reference price
2 |
107.0
|
112.0
|
87.60
|
109.7
|
94.34
|
94.34
|
94.34
|
Announcement Date
|
2/25/20
|
3/2/22
|
2/28/23
|
2/27/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
24,799
|
26,053
|
35,583
|
37,500
|
38,671
|
41,317
|
44,471
|
EBITDA
1 |
3,326
|
-
|
3,570
|
3,683
|
4,176
|
4,720
|
5,480
|
EBIT
1 |
2,031
|
-
|
2,047
|
2,571
|
3,110
|
3,645
|
4,395
|
Operating Margin
|
8.19%
|
-
|
5.75%
|
6.86%
|
8.04%
|
8.82%
|
9.88%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
1,759
|
-
|
2,752
|
3,424
|
4,248
|
Net income
1 |
-
|
-
|
959
|
-
|
1,643
|
2,180
|
2,705
|
Net margin
|
-
|
-
|
2.7%
|
-
|
4.25%
|
5.28%
|
6.08%
|
EPS
2 |
-
|
11.12
|
8.780
|
11.12
|
15.29
|
20.29
|
25.17
|
Free Cash Flow
1 |
-
|
-
|
-2,235
|
-
|
2,401
|
2,357
|
3,115
|
FCF margin
|
-
|
-
|
-6.28%
|
-
|
6.21%
|
5.7%
|
7%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
57.5%
|
49.94%
|
56.84%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
146.14%
|
108.12%
|
115.16%
|
Dividend per Share
2 |
5.700
|
-
|
7.740
|
-
|
3.820
|
6.760
|
-
|
Announcement Date
|
2/25/20
|
3/2/22
|
2/28/23
|
2/27/24
|
-
|
-
|
-
|
Fiscal Period: December |
2023 S1
|
---|
Net sales
1 |
18,404
|
EBITDA
|
-
|
EBIT
|
-
|
Operating Margin
|
-
|
Earnings before Tax (EBT)
|
-
|
Net income
|
-
|
Net margin
|
-
|
EPS
2 |
5.960
|
Dividend per Share
|
-
|
Announcement Date
|
7/26/23
|
Fiscal Period: December |
2019
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
5,345
|
-
|
1,609
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
159
|
2,375
|
Leverage (Debt/EBITDA)
|
-
|
-
|
1.497
x
|
-
|
0.3853
x
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
-2,235
|
-
|
2,401
|
2,357
|
3,115
|
ROE (net income / shareholders' equity)
|
12.1%
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
-
|
-
|
-
|
-
|
129.0
|
142.0
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
833
|
-
|
1,552
|
-
|
1,387
|
1,397
|
1,407
|
Capex / Sales
|
3.36%
|
-
|
4.36%
|
-
|
3.59%
|
3.38%
|
3.16%
|
Announcement Date
|
2/25/20
|
3/2/22
|
2/28/23
|
2/27/24
|
-
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| -13.99% | 534M | | +11.76% | 63.38B | | -3.65% | 46.51B | | +13.40% | 39.91B | | +19.57% | 25.57B | | +7.86% | 18.95B | | +1.44% | 17.58B | | -20.33% | 16.1B | | +0.86% | 14.98B | | -12.98% | 14.78B |
Other Specialty Chemicals
|